Search
+
    SEARCHED FOR:

    NEEDLE PRICKS

    Are Microsofts the new Apple of AI?

    The concentration of investor investment is tracking the spread of AI. The diffusion rate of the tech serves to prick excessive buildup of investor interest in companies that are driving horizontal AI that has economy-wide application. As of now, capital is piling up with the pioneers. But it should move as adapters, enablers and disruptors emerge. Generative AI's productivity-enhancement capabilities will become clearer as smaller companies adapt LLMs for industry-specific use cases.

    Don't ruin your vacation with gaffes & goof-ups! Tourists share where they went wrong while holidaying

    In an effort to help future travelers learn from others' mistakes, The New York Times asked readers to share examples of instances in which they've committed a travel foul or have acted against good tourist etiquette and, maybe, their better judgment.

    What is Guillain-Barré Syndrome? Know about the disorder declared a health emergency in Peru

    In response to a notable surge in Guillain-Barré Syndrome cases, Peruvian authorities have officially declared a 90-day nationwide sanitary emergency.

    Say goodbye to needle pricks! A daily pill may be cure to world's obesity problem

    Novo Nordisk's weight-loss drug, Wegovy, which has so far only been available as an injection, may soon come in pill form. Clinical trials showed that high-dose oral versions of the medication worked almost as well as the injections in paring pounds and improving health.

    Lord's Mark to roll out cheaper sickle cell anaemia test device

    Lord's Mark Industries on Thursday said it has entered into an exclusive collaboration with the Indian Institute of Technology (IIT) Bombay to launch the first ever artificial intelligence-enabled point of care testing equipment to screen sickle cell anaemia, an inherited blood disease.

    Weight loss drugs can wreak havoc on your face, warn experts

    A drug overdose is bad news for your beauty.

    The Economic Times
    BACK TO TOP